Seelos Therapeutics Investor Relations Material
Latest events
Q2 2024
14 Aug, 2024
Q1 2024
14 May, 2024
Access the full event backlog
Slides, Transcripts, and Reports from 13,000 public companies
Latest reports from Seelos Therapeutics Inc
Access all reports
Seelos Therapeutics, Inc. is a biotechnology company focused on developing treatments for central nervous system disorders and other rare diseases. The company’s research and development efforts target neurological, psychiatric, and neurodegenerative conditions. The company is headquartered in New York, New York, and its shares are listed on the OTCQB.
Latest articles
)
The Fifteenth Generation: A Conversation with Pietro Gussalli Beretta
An interview with Pietro Gussalli Beretta on how Beretta Holding blends 500 years of tradition with global growth, innovation, and long-term vision.
10 Jul 2025
)
Citadel: Relentless Optimization at Global Scale
From a Harvard dorm to global dominance, this is the story of how Ken Griffin created one of the best-performing hedge funds of all time.
4 Jul 2025
)
David A. Ricks: Eli Lilly's Chairman and CEO
David Ricks built a decades-long career at Eli Lilly, now leading the giant company through a defining moment in its long pharmaceutical history.
3 Jul 2025
Ticker symbol
SEEL.Q
Country
🇺🇸 United States